Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Metastatic Triple-Negative Breast Cancer (mTNBC).
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I